Compound Detail
CHEMBL612
DEXTROAMPHETAMINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL612 |
| Name | DEXTROAMPHETAMINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | KWTSXDURSIMDCE-QMMMGPOBSA-N |
| Therapeutic | ✓ Yes |
14
Targets
50
Activities
4
Assay Types
1
PK Parameters
20
Publications
11
Known Names
13
Indications
3
Mechanisms
Molecular Properties
135.2
MW (Da)
1.58
ALogP
1
HBA
1
HBD
26.0
PSA (Ų)
0.65
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1955 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dopamine transporter releasing agent | RELEASING AGENT | Sodium-dependent dopamine transporter | ✓ | ✓ |
| Norepinephrine transporter releasing agent | RELEASING AGENT | Sodium-dependent noradrenaline transporter | ✓ | ✓ |
| Synaptic vesicular amine transporter inhibitor | INHIBITOR | Synaptic vesicular amine transporter | ✓ | ✓ |
Indications
Arteriosclerosis Attention Deficit Disorder with Hyperactivity Narcolepsy Substance-Related Disorders Paraganglioma Amphetamine-Related Disorders Cocaine-Related Disorders Multiple Sclerosis Opioid-Related Disorders Schizophrenia Stress Disorders, Post-Traumatic Stroke Bipolar Disorder
ATC Classification
N06BA02
dexamfetamine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Drug Warnings
Black Box Warning
neurotoxicity
Black Box Warning
misuse
Activity Summary
EC50 28 meas. best 8.7
Ki 16 meas. best 7.0
IC50 5 meas. best 6.7
Kd 1 meas. best 5.35
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Trace amine-associated receptor 1 CHEMBL4908 | EC50 | 8.7 | 7.502 | 2.0 | 5 |
| Unchecked CHEMBL612545 | EC50 | 8.15 | 7.4167 | 7.0 | 3 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | EC50 | 8.15 | 8.15 | 7.1 | 1 |
| Trace amine-associated receptor 1 CHEMBL3833 | EC50 | 7.86 | 6.6083 | 13.9 | 6 |
| Sodium-dependent dopamine transporter CHEMBL238 | EC50 | 7.61 | 7.61 | 24.8 | 1 |
| Sodium-dependent dopamine transporter CHEMBL338 | EC50 | 7.61 | 7.605 | 24.8 | 2 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | Ki | 7.0 | 7.0 | 101.0 | 1 |
| Sodium-dependent dopamine transporter CHEMBL238 | Ki | 6.96 | 6.96 | 109.0 | 1 |
| Trace amine-associated receptor 1 CHEMBL5857 | EC50 | 6.85 | 6.275 | 140.0 | 4 |
| Rattus norvegicus CHEMBL376 | IC50 | 6.7 | 6.7 | 200.0 | 1 |
| Sodium-dependent dopamine transporter CHEMBL238 | IC50 | 6.54 | 6.54 | 288.4 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 6.2 | 6.2 | 631.0 | 1 |
| Rattus norvegicus CHEMBL376 | EC50 | 6.1 | 5.53 | 800.0 | 2 |
| Unchecked CHEMBL612545 | Ki | 6.0 | 5.17 | 1000.0 | 2 |
| Trace amine-associated receptor 1 CHEMBL1926495 | EC50 | 6.0 | 6.0 | 1010.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL313 | EC50 | 5.75 | 5.75 | 1765.0 | 2 |
| Sodium-dependent serotonin transporter CHEMBL228 | EC50 | 5.75 | 5.75 | 1770.0 | 1 |
| Serotonin (5-HT) receptor CHEMBL2094123 | Kd | 5.35 | 5.35 | 4466.8 | 1 |
| Sodium-dependent dopamine transporter CHEMBL338 | IC50 | 5.31 | 5.31 | 4900.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 5.24 | 5.24 | 5728.0 | 1 |
| Amine oxidase [flavin-containing] A CHEMBL3358 | Ki | 4.91 | 4.91 | 12200.0 | 1 |
| Amine oxidase [flavin-containing] A CHEMBL1951 | Ki | 4.84 | 4.84 | 14400.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | IC50 | 4.78 | 4.78 | 16595.9 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 10.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 24354319 | 10.1021/jm401316v | Trace amine-associated receptor 1 | 14 |
| 22037049 | 10.1016/j.bmc.2011.10.007 | Trace amine-associated receptor 1 | 9 |
| 28244748 | 10.1021/acs.jmedchem.7b00085 | Rattus norvegicus | 8 |
| 7265121 | 10.1021/jm00135a020 | Mus musculus | 6 |
| 6716406 | 10.1021/jm00371a023 | Mus musculus | 5 |
| 2563772 | 10.1021/jm00123a004 | Mus musculus | 3 |
| 3397993 | 10.1021/jm00403a012 | Amine oxidase [flavin-containing] B | 3 |
| 7392028 | 10.1021/jm00180a006 | Rattus norvegicus | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 20123154 | 10.1016/j.bmc.2010.01.029 | Unchecked | 2 |
| 23602445 | 10.1016/j.bmcl.2013.03.066 | Sodium-dependent serotonin transporter | 2 |
| 20123154 | 10.1016/j.bmc.2010.01.029 | Amine oxidase [flavin-containing] B | 2 |
| 20123154 | 10.1016/j.bmc.2010.01.029 | Amine oxidase [flavin-containing] A | 2 |
| 19345586 | 10.1016/j.bmc.2009.03.025 | Glutamate NMDA receptor | 2 |
| 18602830 | 10.1016/j.bmc.2008.06.009 | Trace amine-associated receptor 1 | 2 |
| 8676127 | 10.1021/np50124a001 | Unchecked | 2 |
| 7143356 | 10.1021/jm00352a020 | Phenylethanolamine N-methyltransferase | 2 |
| 23602445 | 10.1016/j.bmcl.2013.03.066 | Sodium-dependent noradrenaline transporter | 2 |
| 6123601 | 10.1021/jm00347a011 | Rattus norvegicus | 2 |
| 23602445 | 10.1016/j.bmcl.2013.03.066 | Sodium-dependent dopamine transporter | 2 |
Data from ChEMBL 36 via Core Engine